Prof. David A. Sinclair
Genetics at Harvard Medical School
Biography & Research Background
David A. Sinclair, PhD, is Professor of Genetics at Harvard Medical School and Co-Director of the Paul F. Glenn Center for the Biological Mechanisms of Aging. Prof. Sinclair's laboratory established that NAD+ levels decline with age and that this decline compromises the activity of sirtuins (SIRT1), enzymes critical for DNA repair and longevity. His work has focused on developing 'NAD-boosting' molecules (NMN) to restore metabolic function and extend healthspan. He authored seminal reviews: 'Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds' (2016) and 'Therapeutic potential of NAD-boosting molecules' (2018). David A. Sinclair is being referenced as one of the leading scientists involved in NAD+ research. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure US Peptide and this doctor.
External Profiles
Authored Research Profiles (1)
Prof. David A. Sinclair is referenced as a leading researcher in the following peptide research profiles on Pure U.S. Peptides:
Prof. David A. Sinclair is being referenced as one of the leading scientists involved in the research and development of the peptides listed above. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of any product for any reason. There is no affiliation or relationship, implied or otherwise, between Pure U.S. Peptides and this researcher. The purpose of citing the researcher is to acknowledge, recognize, and credit the exhaustive research and development efforts conducted by the scientists studying these peptides.